In vivo, suppression of the IL‐17A pathway is associated with decreased tumor growth,6, 8, 9, 10, 11, 12, 13 increased tumor cell apoptosis,6, 10, 11, 14 decreased metastasis, and increased survival.9 The gene discussed is IL17A; the disease is neoplasm.